Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7576
CALL
Golub Capital BDC
GBDC
$3.39B
| $756K | ﹤0.01% |
58,300
+33,800
| +138% | +$484K |
|
7577
CALL
Myriad Genetics
MYGN
$275M
| $756K | ﹤0.01% |
41,600
-6,300
| -13% | -$131K |
|
7578
Offerpad Solutions
OPAD
$19.9M
| $756K | ﹤0.01% |
2,311
+2,210
| +2,188% | +$1.48M |
|
7579
Red Violet
RDVT
$1.09B
| $756K | ﹤0.01% |
39,723
+22,592
| +132% | +$555K |
|
7580
CALL
Schwab U.S Small- Cap ETF
SCHA
$23.3B
| $756K | ﹤0.01% |
38,800
+3,600
| +10% | +$77K |
|
7581
CALL
Credicorp
BAP
$29.3B
| $755K | ﹤0.01% |
6,300
-3,600
| -36% | -$495K |
|
7582
CALL
Exagen
XGN
$160M
| $755K | ﹤0.01% |
131,500
+22,700
| +21% | +$132K |
|
7583
Bar Harbor Bankshares
BHB
$680M
| $754K | ﹤0.01% |
29,158
-11,196
| -28% | -$296K |
|
|
INDT
7584
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $754K | ﹤0.01% |
12,703
-4,882
| -28% | -$325K |
|
7585
ATN International
ATNI
$484M
| $753K | ﹤0.01% |
+16,032
| New | +$679K |
|
7586
VictoryShares US Large Cap High Div Volatility Wtd ETF
CDL
$409M
| $751K | ﹤0.01% |
12,927
-5,952
| -32% | -$365K |
|
7587
CALL
EXL Service
EXLS
$5.38B
| $751K | ﹤0.01% |
25,500
-3,000
| -11% | -$84.8K |
|
7588
PUT
Omnicell
OMCL
$1.64B
| $751K | ﹤0.01% |
6,600
-1,200
| -15% | -$138K |
|
7589
PUT
Reinsurance Group of America
RGA
$16B
| $751K | ﹤0.01% |
6,400
-3,500
| -35% | -$406K |
|
|
CRON
7590
Cronos Group
CRON
$1.18B
| $749K | ﹤0.01% |
265,519
-82,763
| -24% | -$258K |
|
7591
CALL
NMI Holdings
NMIH
$3.43B
| $749K | ﹤0.01% |
45,000
-46,500
| -51% | -$845K |
|
7592
Nelnet
NNI
$4.5B
| $749K | ﹤0.01% |
8,781
-8,802
| -50% | -$731K |
|
7593
Phibro Animal Health
PAHC
$1.41B
| $749K | ﹤0.01% |
39,123
-61,075
| -61% | -$1.16M |
|
7594
CALL
Vanguard FTSE All-World ex-US ETF
VEU
$69.6B
| $749K | ﹤0.01% |
15,000
+2,700
| +22% | +$145K |
|
7595
PUT
Coca-Cola Europacific Partners
CCEP
$47.5B
| $748K | ﹤0.01% |
14,500
+8,000
| +123% | +$410K |
|
7596
Mid Penn Bancorp
MPB
$965M
| $748K | ﹤0.01% |
27,744
+5,834
| +27% | +$155K |
|
7597
TPG
TPG
$8.35B
| $748K | ﹤0.01% |
31,298
-376,942
| -92% | -$10.2M |
|
7598
CALL
Vanguard Extended Market ETF
VXF
$31.7B
| $747K | ﹤0.01% |
5,700
-1,400
| -20% | -$204K |
|
7599
Woodward
WWD
$21.6B
| $747K | ﹤0.01% |
8,077
-62,519
| -89% | -$6.51M |
|
7600
Avantis Responsible Emerging Markets Equity ETF
AVSE
$216M
| $746K | ﹤0.01% |
17,042
-31,758
| -65% | -$1.47M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.